Syros Pharmaceuticals - 48 Year Dividend History | SYRS

Historical dividend payout and yield for Syros Pharmaceuticals (SYRS) since 1971. The current TTM dividend payout for Syros Pharmaceuticals (SYRS) as of June 21, 2019 is $0.00. The current dividend yield for Syros Pharmaceuticals as of June 21, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.290B $0.002B
Syros Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on treatments for cancer and immune-mediated diseases as well as building a pipeline of gene control medicines. The company's product pipeline includes SY-1425, a selective RARa agonist for genomically defined subsets of patients with relapsed or refractory acute myeloid leukemia and relapsed high-risk myelodysplastic syndrome and SY-1365, a selective CDK7 inhibitor for acute leukemia which is in preclinical stage. Syros Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $114.125B 12.90
Gilead Sciences (GILD) United States $88.452B 10.74
Bio-Techne Corp (TECH) United States $7.965B 54.34